Term
| UTI cost to healthcare system |
|
Definition
#1 nosocomial infection (30%)
#1 community acquired infection (some estimates say upper respiratory) |
|
|
Term
|
Definition
|
|
Term
|
Definition
| caused by G+ staph species (staph a.) |
|
|
Term
| male acquires a UTI in response to |
|
Definition
|
|
Term
|
Definition
asymptomatic presence. does not mean an infection.
20% of female population |
|
|
Term
|
Definition
first stage of noticable bladder infection
mild - mod. easily Tx
Caution: 30% have renal tissue involv. with no S/S
onset: 24 - 48 hrs post inoculation
dysuria, pyuria, frequency, poss. low grade temp |
|
|
Term
|
Definition
infection of renal tissue
acute or chronic
chronic --> could it cause permanent damage?
aggressive Tx: IV antibiotics x 48 hrs, followed by PO for 7-10 days
E. Coli 80% of time |
|
|
Term
|
Definition
indicates a Co-morbidity (blockage of some kind)
all locations of UTI's
diabetes obstructions are largest concern
less predictable
|
|
|
Term
|
Definition
bactrim, septra (#1)
cipro, levaquin - back ups |
|
|
Term
| common "complicated" offending bacteria |
|
Definition
E. Coli (most common)
Staph a.
Pseudomonas
Klebsiella
Candida
|
|
|
Term
|
Definition
urinate
wait for secondary let-down
|
|
|
Term
|
Definition
painful urination
inc. WBC
pos. nitrogen dipstick |
|
|
Term
| three ways to dose antiBx for UTI's |
|
Definition
7-10 days reg. doses
3 large doses
1 huge dose |
|
|
Term
| ciprofloxacin (a flouroquinolone) kinetics |
|
Definition
broad spectrum, cidal
inhibits DNA production
suppress symptoms within 3-5 days
G+ small group, G- large group
very high solubility --> very high conc. in urine
Does not cross BBB
E. Coli, Klebsiella, Pseudomonas |
|
|
Term
| Ciprofloxacin ( a flouroquinolone) SE |
|
Definition
tends to kill bacteria in bowel
well tolerated
N/V/D, abd cramping
Dizziness, HA
candida vaginitis
caution w/ tendons (kids under 18yr)
AAPC (C-diff) |
|
|
Term
| Ciprofloxacin (a flouroquinolone) ADR |
|
Definition
do not mix with: Fe++, Zinc, Al-, Mg++, and no dairy or calcium fortified drinks 6 hrs before or after dose.
NSAIDS
warfarin (effectiveness goes up)
thophyiline (30% inc. in levels) |
|
|
Term
|
Definition
Broad spectrum, Static
G+ and G-, MRSA
dec. folic acid prod.-->dec. RNA/DNA prod.
high solubility-->high concentration in urine |
|
|
Term
|
Definition
hypersensitivity
blood dyscrasias (anemia)
urine crystal formations |
|
|
Term
|
Definition
warfarin (inc. risk for bleeding)
oral hypoglycemics
cross sensitivity with Lasix and thiazides
|
|
|
Term
|
Definition
broad spectrum
static and cidal
G+ small group, G- large group
dec. folic acid-->dec. RNA/DNA
high solubility-->high conc. in urine
MRSA and E. coli |
|
|
Term
|
Definition
GI (N/V)
itching and rash
blood dyscrasias:
anemia
neutropenia
thrombocytopenia |
|
|
Term
|
Definition
combo of Sulfanomides and trimethoprim
suppresses symptoms w/in 3-5 days
Synergistic reaction (1+1=3)
does not potentiate side of effects of each other
tends to kill bacteria in bowels |
|
|
Term
|
Definition
|
|
